x
Academic research constantly creates and disperses seeds of scientific insight. Occasionally, these seeds land on the fertile soil of commercial interest, and a new business takes root. The innovation pathway from university laboratory to start-up company is an essential part of the dynamic. This Outlook profiles the five companies selected as Finalists for The Spinoff Prize 2023, as well as the seven that made the long-list. All 12 were recognized by the panel of judges as having extraordinary potential to develop products and technologies that will change the way we live and work.
This Nature Outlook is editorially independent, produced with financial support from a third party. About this content.
Nature introduces the finalists and those that made it on to the longlist for this year’s award.
Outlook24 May 2023Nature
Clinical trials, industry partnerships and other milestones reached by previous finalists of The Spinoff Prize.
Outlook24 May 2023Nature
Sponsor Feature24 May 2023
Alongside developing a quantum computer, one group of scientists is selling its components to other researchers.
Outlook24 May 2023Nature
A method driven by renewable energy could end the need for fossil fuels in fertilizer production.
Outlook24 May 2023Nature
An architecture for quantum computers based on parity is attracting money from government and industry.
Outlook24 May 2023Nature
High-resolution imaging quickly identifies blood clots before they inflict major damage.
Outlook24 May 2023Nature
A nature-inspired adhesive offers hope for wound healing and haemorrhage control.
Outlook24 May 2023Nature
Advances in materials yield safer, cheaper and denser energy storage.
Outlook24 May 2023Nature
Unusual vocal patterns can give clues that help to detect conditions such as Alzheimer’s disease.
Outlook24 May 2023Nature
A reproducible cell-culture system could help to evaluate new therapies for disorders that affect the brain.
Outlook24 May 2023Nature
Photocatalysis using light-emitting diodes could reduce the amount of carbon dioxide emitted by industrial chemical processes.
Outlook24 May 2023Nature
The antibody drug is moving closer to being tested in people with advanced stages of cancer.
Outlook24 May 2023Nature
Manipulating genetic molecules could return cells to a younger state.
Outlook24 May 2023Nature
Intermediate states show promise as drug targets.
